Meeting ReportOncology: Clinical Therapy and Diagnosis
[18F]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
Olayinka Abiodun-Ojo, Ashesh Jani, Akinyemi Akintayo, Mehrdad Alemozaffar, Oladunni Akin-Akintayo, Oluwaseun Odewole, Funmialyo Tade, Peter Nieh, Viraj Master, Pretesh Patel, Joseph Shelton, Omer Kucuk, Zhengjia Chen, Bruce Hershatter, Bridget Fielder, Raghuveer Halkar and David Schuster
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1576;
Olayinka Abiodun-Ojo
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Ashesh Jani
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Akinyemi Akintayo
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Mehrdad Alemozaffar
1Atlanta GA United States
Oladunni Akin-Akintayo
5Emory Univ. Division of Nuclear Medicine Scottdale GA United States
Oluwaseun Odewole
9Morehouse School of Medicine Atlanta GA United States
Funmialyo Tade
2Oak park IL United States
Peter Nieh
4Emory Clinic Atlanta GA United States
Viraj Master
3Emory Atlanta GA United States
Pretesh Patel
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Joseph Shelton
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Omer Kucuk
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Zhengjia Chen
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Bruce Hershatter
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Bridget Fielder
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
Raghuveer Halkar
8Emory University Hospital Atlanta GA United States
David Schuster
6Emory University Atlanta GA United States
7Emory University Atlanta GA United States
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
[18F]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
Olayinka Abiodun-Ojo, Ashesh Jani, Akinyemi Akintayo, Mehrdad Alemozaffar, Oladunni Akin-Akintayo, Oluwaseun Odewole, Funmialyo Tade, Peter Nieh, Viraj Master, Pretesh Patel, Joseph Shelton, Omer Kucuk, Zhengjia Chen, Bruce Hershatter, Bridget Fielder, Raghuveer Halkar, David Schuster
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1576;
[18F]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
Olayinka Abiodun-Ojo, Ashesh Jani, Akinyemi Akintayo, Mehrdad Alemozaffar, Oladunni Akin-Akintayo, Oluwaseun Odewole, Funmialyo Tade, Peter Nieh, Viraj Master, Pretesh Patel, Joseph Shelton, Omer Kucuk, Zhengjia Chen, Bruce Hershatter, Bridget Fielder, Raghuveer Halkar, David Schuster
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1576;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.